Syndrome de Sjögren primitif : critères diagnostiques et de suivi

Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Hélène Chifflot(Hôpital d'Hautepierre), Christelle Sordet, Emmanuel Chatelus(Laboratoire National de Référence)

Revue du Rhumatisme Monographies

March 26, 2010

10.1016/j.monrhu.2010.01.007

Cited by 0

Related Papers

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

|New England Journal of Medicine|2018|501

Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review

|Seminars in Arthritis and Rheumatism|2007|456

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

|Annals of the Rheumatic Diseases|2014|432

Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses

|Blood|1997|346

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

|Annals of the Rheumatic Diseases|2012|207